Roupret, 2013, European guidelines on upper urinary tract urothelial carcinomas: 2013 update, Eur Urol, 63, 1059, 10.1016/j.eururo.2013.03.032
Siegel, 2012, Cancer statistics, 2012, CA: Cancer J Clin, 62, 10
Siegel, 2012, Cancer treatment and survivorship statistics, 2012, CA: Cancer J Clin, 62, 220
Shariat, 2010, Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy, BJU Int, 105, 1672, 10.1111/j.1464-410X.2009.09072.x
Lughezzani, 2010, Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database, Urology, 75, 321, 10.1016/j.urology.2009.09.048
Rink, 2013, Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy, Eur Urol, 63, 1082, 10.1016/j.eururo.2012.06.029
Lord, 1999, Nephropathy caused by Chinese herbs in the UK, Lancet, 354, 481, 10.1016/S0140-6736(99)03380-2
Colin, 2009, Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract, BJU Int, 104, 1436, 10.1111/j.1464-410X.2009.08838.x
Debelle, 2008, Aristolochic acid nephropathy: a worldwide problem, Kidney Int, 74, 158, 10.1038/ki.2008.129
Markovic, 2005, Decreasing incidence of urothelial cancer in a Balkan endemic nephropathy region in Serbia. A surgery based study from 1969 to 1998, Pathol Biol, 53, 26, 10.1016/j.patbio.2004.01.008
Grollman, 2007, Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia, J Am Soc Nephrol, 18, 2817, 10.1681/ASN.2007050537
Tan, 2008, Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan, BJU Int, 102, 48, 10.1111/j.1464-410X.2008.07565.x
McCredie, 1983, Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women, Br J Urol, 55, 220, 10.1111/j.1464-410X.1983.tb06561.x
McCredie, 1993, Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis, Int J Cancer, 53, 245, 10.1002/ijc.2910530212
Crockett, 2011, Upper urinary tract carcinoma in Lynch syndrome cases, J Urol, 185, 1627, 10.1016/j.juro.2010.12.102
Roupret, 2008, Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum, Eur Urol, 54, 1226, 10.1016/j.eururo.2008.08.008
Audenet, 2012, A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool, BJU Int, 110, E583, 10.1111/j.1464-410X.2012.11298.x
Yates, 2013, Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours, World J Urol, 31, 21, 10.1007/s00345-012-0946-6
Catto, 2006, Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance, J Urol, 175, 2323, 10.1016/S0022-5347(06)00256-4
Catto, 2007, Behavior of urothelial carcinoma with respect to anatomical location, J Urol, 177, 1715, 10.1016/j.juro.2007.01.030
van Oers, 2009, FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours, Eur Urol, 55, 650, 10.1016/j.eururo.2008.06.013
Hafner, 2001, Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract, Oncogene, 20, 4910, 10.1038/sj.onc.1204671
Hafner, 2002, Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies, Int J Cancer, 101, 1, 10.1002/ijc.10544
Roupret, 2005, Microsatellite instability and transitional cell carcinoma of the upper urinary tract, BJU Int, 96, 489, 10.1111/j.1464-410X.2005.05671.x
Roupret, 2005, Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma, Urology, 65, 1233, 10.1016/j.urology.2005.01.019
Novara, 2008, Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract, BJU Int, 101, 1368, 10.1111/j.1464-410X.2008.07438.x
Xylinas, 2012, Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence, Eur Urol, 61, 1069, 10.1016/j.eururo.2012.02.042
Zigeuner, 2006, Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location, BJU Int, 98, 1181, 10.1111/j.1464-410X.2006.06519.x
Azemar, 2011, Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance, Urol Oncol, 29, 130, 10.1016/j.urolonc.2009.06.003
Sanderson, 2007, Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments, BJU Int, 100, 11, 10.1111/j.1464-410X.2007.06841.x
Kikuchi, 2009, Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma, J Clin Oncol, 27, 612, 10.1200/JCO.2008.17.2361
Lughezzani, 2012, Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature, Eur Urol, 62, 100, 10.1016/j.eururo.2012.02.030
Olgac, 2004, Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases, Am J Surg Pathol, 28, 1545, 10.1097/00000478-200412000-00001
Perez-Montiel, 2006, High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants, Mod Pathol, 19, 494, 10.1038/modpathol.3800559
Sobin, 2009, TNM Classification of malignant tumours, 258
Verhoest, 2011, Predictive factors of recurrence and survival of upper tract urothelial carcinomas, World J Urol, 29, 495, 10.1007/s00345-011-0710-3
Shariat, 2011, Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma, World J Urol, 29, 481, 10.1007/s00345-010-0594-7
Berod, 2012, The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study, BJU Int, 110, E1035, 10.1111/j.1464-410X.2012.11195.x
Martinez-Salamanca, 2012, Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study, BJU Int, 109, 1155, 10.1111/j.1464-410X.2011.10479.x
Ehdaie, 2011, Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma, J Urol, 186, 66, 10.1016/j.juro.2011.03.031
Shariat, 2012, Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM Classification, Eur Urol, 62, 224, 10.1016/j.eururo.2012.01.019
Lopez-Beltran, 2004, Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis, Eur Urol, 45, 257, 10.1016/j.eururo.2003.09.018
Inman, 2009, Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality, Cancer, 115, 2853, 10.1002/cncr.24339
Kamihira, 2009, Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan, Eur Urol, 55, 1397, 10.1016/j.eururo.2009.03.003
Lughezzani, 2009, Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients, Eur J Cancer, 45, 3291, 10.1016/j.ejca.2009.06.016
Novara, 2007, Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers, Cancer, 110, 1715, 10.1002/cncr.22970
Park, 2009, The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival, J Urol, 182, 894, 10.1016/j.juro.2009.05.040
Brown, 2006, Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?, BJU Int, 98, 1176, 10.1111/j.1464-410X.2006.06524.x
Sauter, 2004, Noninvasive urothelial neoplasias: WHO classification of noninvasive papillary urothelial tumors, 110
Li, 2008, Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients, Eur Urol, 54, 1127, 10.1016/j.eururo.2008.01.054
Li, 2009, The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy, J Urol, 182, 451, 10.1016/j.juro.2009.04.026
Margulis, 2009, Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration, Cancer, 115, 1224, 10.1002/cncr.24135
Ouzzane, 2011, Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy, Eur Urol, 60, 1258, 10.1016/j.eururo.2011.05.049
Yafi, 2012, Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy, BJU Int, 110, E7, 10.1111/j.1464-410X.2011.10792.x
Isbarn, 2009, Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma, J Urol, 182, 2177, 10.1016/j.juro.2009.07.035
Kondo, 2010, Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival, Int J Urol, 17, 848, 10.1111/j.1442-2042.2010.02610.x
Novara, 2010, Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study, Eur Urol, 57, 1064, 10.1016/j.eururo.2009.12.029
Fritsche, 2012, Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma, Urol Oncol, 30, 666, 10.1016/j.urolonc.2010.07.010
Lughezzani, 2010, A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma, Urology, 75, 118, 10.1016/j.urology.2009.07.1296
Xylinas, 2013, Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy, J Urol, 189, 468, 10.1016/j.juro.2012.09.036
Roscigno, 2009, Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer, Urology, 74, 1070, 10.1016/j.urology.2009.04.084
Bolenz, 2009, Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density, BJU Int, 103, 302, 10.1111/j.1464-410X.2008.07988.x
Pieras, 2010, Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma, BJU Int, 106, 1319, 10.1111/j.1464-410X.2010.09341.x
Zigeuner, 2010, Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract, Eur Urol, 57, 575, 10.1016/j.eururo.2009.11.035
Brien, 2010, Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma, J Urol, 184, 69, 10.1016/j.juro.2010.03.030
Ito, 2011, Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma, J Urol, 185, 1621, 10.1016/j.juro.2010.12.035
Ng, 2011, Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?, Urol Oncol, 29, 27, 10.1016/j.urolonc.2008.10.023
Eltz, 2008, Molecular and histological markers in urothelial carcinomas of the upper urinary tract, BJU Int, 102, 532, 10.1111/j.1464-410X.2008.07659.x
Izquierdo, 2010, Molecular characterization of upper urinary tract tumours, BJU Int, 106, 868, 10.1111/j.1464-410X.2009.09135.x
Tanaka, 2014, The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study, Eur Urol, 65, 227, 10.1016/j.eururo.2012.11.050
Drouin, 2013, A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting, World J Urol, 31, 109, 10.1007/s00345-012-1008-9
Xylinas, 2013, Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma, World J Urol, 31, 31, 10.1007/s00345-012-0947-5
Margulis, 2010, Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract, J Urol, 184, 453, 10.1016/j.juro.2010.03.142
Favaretto, 2012, Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma, BJU Int, 109, 77, 10.1111/j.1464-410X.2011.10288.x
Cha, 2012, Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma, Eur Urol, 61, 818, 10.1016/j.eururo.2012.01.021
Yates, 2012, Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram, Br J Cancer, 106, 1083, 10.1038/bjc.2012.64
Roupret M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, et al. Prediction of cancer-specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized post-operative nomogram using decision curve analysis. J Urol 2014 Jan 21 [Epub ahead of print].
Raman, 2011, Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?, Urol Oncol, 29, 716, 10.1016/j.urolonc.2009.11.007
Fritz, 2006, Multiphasic multidetector-row CT (MDCT) in detection and staging of transitional cell carcinomas of the upper urinary tract, Eur Radiol, 16, 1244, 10.1007/s00330-005-0078-0
Maheshwari, 2010, Split-bolus MDCT urography: upper tract opacification and performance for upper tract tumors in patients with hematuria, AJR Am J Roentgenol, 194, 453, 10.2214/AJR.09.3228
Sudakoff, 2008, Multidetector computerized tomography urography as the primary imaging modality for detecting urinary tract neoplasms in patients with asymptomatic hematuria, J Urol, 179, 862, 10.1016/j.juro.2007.10.061
Cowan, 2012, CT urography for hematuria, Nat Rev Urol, 9, 218, 10.1038/nrurol.2012.32
Cowan, 2007, Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour, BJU Int, 99, 1363, 10.1111/j.1464-410X.2007.06766.x
Van Der Molen, 2008, CT urography: definition, indications and techniques. A guideline for clinical practice, Eur Radiol, 18, 4, 10.1007/s00330-007-0792-x
Dillman, 2008, Detection of upper tract urothelial neoplasms: sensitivity of axial, coronal reformatted, and curved-planar reformatted image-types utilizing 16-row multi-detector CT urography, Abdom Imaging, 33, 707, 10.1007/s00261-008-9360-3
Vrtiska, 2009, Spatial resolution and radiation dose of a 64-MDCT scanner compared with published CT urography protocols, AJR Am J Roentgenol, 192, 941, 10.2214/AJR.07.2679
Takahashi, 2010, Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy, J Urol, 183, 1330, 10.1016/j.juro.2009.12.031
Clements, 2012, High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection, J Endourol, 26, 398, 10.1089/end.2011.0426
Rojas, 2013, Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma, Urol Oncol, 31, 1696, 10.1016/j.urolonc.2012.05.010
Smith, 2011, Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management, Urology, 78, 82, 10.1016/j.urology.2011.02.038
Cornu, 2010, Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma, World J Urol, 28, 151, 10.1007/s00345-009-0494-x
Audenet, 2012, Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract, BJU Int, 109, 608, 10.1111/j.1464-410X.2011.10363.x
Messer, 2011, Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma, BJU Int, 108, 701
Chen, 2008, Is there a role for FISH in the management and surveillance of patients with upper tract transitional-cell carcinoma?, J Endourol, 22, 1371, 10.1089/end.2008.0096
Colin, 2012, Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study, BJU Int, 110, 1134, 10.1111/j.1464-410X.2012.10960.x
Colin, 2012, Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival, Ann Surg Oncol, 19, 3613, 10.1245/s10434-012-2453-9
Capitanio, 2009, Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases, Eur Urol, 56, 1, 10.1016/j.eururo.2009.03.072
Ni, 2012, Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies, Eur Urol, 61, 1142, 10.1016/j.eururo.2012.02.019
Waldert, 2010, A delay in radical nephroureterectomy can lead to upstaging, BJU Int, 105, 812, 10.1111/j.1464-410X.2009.08821.x
Phe, 2011, Does the surgical technique for management of the distal ureter influence the outcome after nephroureterectomy?, BJU Int, 108, 130, 10.1111/j.1464-410X.2010.09835.x
Roscigno, 2011, Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer, Eur Urol, 60, 776, 10.1016/j.eururo.2011.07.009
Babjuk, 2013, EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013, Eur Urol, 64, 639, 10.1016/j.eururo.2013.06.003
Herrmann, 2012, EAU guidelines on laser technologies, Eur Urol, 61, 783, 10.1016/j.eururo.2012.01.010
Roupret, 2007, Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection, Eur Urol, 51, 709, 10.1016/j.eururo.2006.07.019
Audenet, 2013, Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes, World J Urol, 31, 45, 10.1007/s00345-012-0949-3
O’Brien, 2011, Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial), Eur Urol, 60, 703, 10.1016/j.eururo.2011.05.064
Audenet, 2013, The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC), Urol Oncol, 31, 407, 10.1016/j.urolonc.2010.07.016
Vassilakopoulou, 2011, Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study, Cancer, 117, 5500, 10.1002/cncr.26172
Birtle, 2012, Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (TCC) - opening of the peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (POUT) Trial, BJU Int, 110, 919, 10.1111/j.1464-410X.2012.11413.x
Czito, 2004, Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter, J Urol, 172, 1271, 10.1097/01.ju.0000137910.38441.8a
Pfister, 2013, Recommandations du CCAFU 2013 : tumeurs de la voie excrétrice supérieure, Prog Urol, 23, S126, 10.1016/S1166-7087(13)70050-2